BusinessAssembly Biosciences Announces Key Additions to Microbiome TeamBy Nasdaq OMXSep 28, 2016, 11:01 AM UTC
BusinessAssembly Biosciences Announces Key Additions to Microbiome TeamBy Nasdaq OMXSep 28, 2016, 11:01 AM UTC
BusinessAssembly Biosciences Announces Participation in HBV Scientific Meetings in China and South KoreaBy Nasdaq OMXSep 21, 2016, 11:30 AM UTC
BusinessAssembly Biosciences to Present Data at The International Liver Congress(TM) 2016 that Supports Advancing Its CpAM Candidates into HBV Clinical TrialsBy Nasdaq OMXApr 13, 2016, 11:00 AM UTC
BusinessAssembly Biosciences to Present Data on New Series of HBV Core Protein Allosteric Modifiers at The International Liver Congress™ 2016By Nasdaq OMXMar 30, 2016, 11:30 AM UTC
BusinessClinical Study Shows Assembly Biosciences' Oral Gemicel™ Technology Can Achieve Targeted Delivery to the Lower GI Tract for Microbiome and Other ApplicationsBy Nasdaq OMXDec 9, 2015, 12:00 PM UTC
